Table 1.
Total | Deceased within 30 days | Alive at 30 days | |
---|---|---|---|
Sample size | 99 | 16 | 83 |
Male, count (%) | 56 (57) | 13 (81) | 43 (52) |
Age, mean ± SD, years | 55.81 ± 14.05 | 61.37 ± 13.77 | 54.73 ± 13.92 |
BMI mean ± SD, kg/m2 | 32.61 ± 8.33, N = 96 | 34.17 ± 10.74, N = 15 | 32.32 ± 7.86, N = 81 |
Length of stay, mean ± SEM, days | 10.89 ± 9.62 | 16.10 ± 7.21 | 9.89 ± 9.73 |
Charlson Comorbidity Index, mean | 2 (1–4) | 4 (2–6.25) | 2 (1–4) |
Race, count (%) | |||
Black/AA | 29 (29) | 7 (44) | 22 (26) |
Hispanic | 61 (62) | 8 (50) | 53 (64) |
White/Caucasian | 6 (6) | 1 (6) | 5 (6) |
Did not identify | 3 (3) | 0 (0) | 3 (4) |
Comorbidities, count (%) | |||
Type II diabetes | 48 (48) | 8 (50) | 40 (48) |
Congestive heart failure | 14 (14) | 3 (19) | 11 (13) |
Myocardial infarction | 9 (9) | 2 (13) | 7 (8) |
Chronic kidney disease | 10 | 2 (13) | 8 (10) |
Liver disease | 9 (9) | 1 (6) | 8 (10) |
COPD | 7 (7) | 1 (6) | 6 (7) |
Hepatitis C | 9 (9) | 2 (13) | 7 (8) |
Hepatitis B | 1 (1) | 1 (6) | 0 (0) |
A Welch two sided t test and a Pearson chi-squared test or fisher exact test were used to make comparisons for continuous and categorical data, respsectively, with p < 0.05 indicating statistical significance
Sample sizes are indicated next to data point if different from main group heading
COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; SD, standard deviation